Development of methodology for conducting clinical trials in frontotemporal lobar degeneration
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
To design clinical trials for the frontotemporal lobar degenerations (FTLD), knowledge about measurement of disease progression is needed to estimate power and enable the choice of optimal outcome measures. The aim here was to conduct a multicentre, 1 year replica of a clinical trial in patients with one of four FTLD syndromes, behavioural variant frontotemporal dementia (bvFTD), progressive nonfluent aphasia (PNFA), progressive logopenic aphasia (PLA) and semantic dementia (SMD). Patients with one of the four FTLD syndromes were recruited from five academic medical centres over a 2 year period. Standard operationalized diagnostic criteria were used. In addition to clinical inclusion and exclusion criteria, patients were required to exhibit focal frontal, temporal or insular brain atrophy or dysfunction by neuroimaging. Patients underwent neuropsychological, functional, behavioural, neurological and MR imaging assessment at baseline and approximately 12 months later. Potential outcome measures were examined for their rates of floor and ceiling values at baseline and end of study, their mean changes and variances. The neuropsychological tests were combined into two cognitive composites -- one for language functions and the other for executive functions. There were 107 patients who underwent baseline assessment and 78 who completed a follow-up assessment within 10-16 months. Two global measures, the FTLD-modified Clinical Dementia Rating (FTLD-modified CDR) and the Clinical Global Impression of Change (CGIC) demonstrated decline in the majority of patients. Several cognitive measures showed negligible floor or ceiling scores either at baseline or follow-up. Scores declined at follow-up in the majority of patients. The cognitive, executive and combined composites were shown to be sensitive to change across all FTLD syndromes. Patients improved at follow-up on the behavioural scales -- the Frontal Behavioural Inventory (22%) and the Neuropsychiatric Inventory (28%) -- suggesting that these instruments may not be ideal for clinical trial use. It was feasible to recruit FTLD patients in a simulated multi-centre trial. There are several candidate outcome measures -- including the FTLD-CDR and the cognitive composites -- that could be used in clinical trials across the spectrum of FTLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings showed the FTLD-CDR demonstrated annual decline over years in genetic and sporadic FTD population (Knopman et al., 2008; Mioshi et al., 2017; Staffaroni et al., 2019a,b; Anderl-Straub et al., 2021; Lima-Silva et al., 2021).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The adapted version of the CDR, FTLD-modified Clinical Dementia Rating scale (FTLD-CDR); (Knopman et al., 2008), added domains of language and behavior to the original scale, accounting for the most prominent symptoms in bvFTD (Knopman et al., 2011).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
In the citing paper
“Overall, literature demonstrated these measures can detect functional decline in bvFTD over extensive follow-up time (1–7 years) (Knopman et al., 2008; Mioshi and Hodges, 2009; O’Connor et al., 2016; Staffaroni et al., 2019b; Giebel et al., 2021).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
In the citing paper
“While one study did not report such behavioral inflection point during follow-up (Linds et al., 2015), the relative reduction of positive symptoms may show improvement of behavioral scores over time (Knopman et al., 2008).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
In the citing paper
“However, given cognitive heterogeneity, combining multiple test scores into (executive functioning, language and memory) composites is known to increase sensitivity to change and ability to detect annual decline in bvFTD (Knopman et al., 2008).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Self-citationKaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
Research works printed but not linked: 3
- Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. 2nd. San Antonio, TX: The Psychological Crop;; 2000. [Google Scholar]
- Sulestrowska, 1958, Medline Rows With NULL issns Will Point To This, 8, 271
- Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation; 1981. [Google Scholar]
Cited by
Frontotemporal Lobar Degeneration: Epidemiology, Pathophysiology, Diagnosis and Management
Rabinovici, G. D., & Miller, B. L. (2010) · CNS Drugs · doi:10.2165/11533100-000000000-00000 · Cited by 501
Self-citationBehavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management
Piguet, O., Hornberger, M., Mioshi, E., & Hodges, J. R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70299-4 · Cited by 496
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
Rohrer, J. D., Woollacott, I. O. C., Dick, K. M., Brotherhood, E., Gordon, E., Fellows, A., Toombs, J., Druyeh, R., Cardoso, M. J., Ourselin, S., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003154 · Cited by 432
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech
Josephs, K. A., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Master, A. V., Lowe, V. J., Jack, C. R., & Whitwell, J. L. (2012) · Brain · doi:10.1093/brain/aws032 · Cited by 419
Primary progressive aphasia: clinicopathological correlations
Grossman, M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.216 · Cited by 414
Clinical staging and disease progression in frontotemporal dementia
Mioshi, E., Hsieh, S., Savage, S., Hornberger, M., & Hodges, J. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e04070 · Cited by 362
Boxer, A. L., Knopman, D. S., Kaufer, D. I., Grossman, M., Onyike, C., Graf-Radford, N., Mendez, M., Kerwin, D., Lerner, A., Wu, C.-K., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70320-4 · Cited by 228
Self-citationPlasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Heller, C., Foiani, M. S., Moore, K., Convery, R., Bocchetta, M., Neason, M., Cash, D. M., Thomas, D., Greaves, C. V., Woollacott, I. O., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321954 · Cited by 182
Miyagawa, T., Brushaber, D., Syrjanen, J., Kremers, W., Fields, J., Forsberg, L. K., Heuer, H. W., Knopman, D., Kornak, J., Boxer, A., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12033 · Cited by 165
Self-citationNetwork degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers
Lee, S. E., Sias, A. C., Mandelli, M. L., Brown, J. A., Brown, A. B., Khazenzon, A. M., Vidovszky, A. A., Zanto, T. P., Karydas, A. M., Pribadi, M., et al. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.12.006 · Cited by 165
Self-citationAltered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion
Lee, S. E., Khazenzon, A. M., Trujillo, A. J., Guo, C. C., Yokoyama, J. S., Sha, S. J., Takada, L. T., Karydas, A. M., Block, N. R., Coppola, G., et al. (2014) · Brain · doi:10.1093/brain/awu248 · Cited by 157
Self-citationCotelli, M., Manenti, R., Petesi, M., Brambilla, M., Cosseddu, M., Zanetti, O., Miniussi, C., Padovani, A., & Borroni, B. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131427 · Cited by 155
Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease
Illán-Gala, I., Lleo, A., Karydas, A., Staffaroni, A. M., Zetterberg, H., Sivasankaran, R., Grinberg, L. T., Spina, S., Kramer, J. H., Ramos, E. M., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011226 · Cited by 150
Self-citationTherapy and clinical trials in frontotemporal dementia: past, present, and future
Tsai, R. M., & Boxer, A. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13640 · Cited by 143
Tsai, R. M., Miller, Z., Koestler, M., Rojas, J. C., Ljubenkov, P. A., Rosen, H. J., Rabinovici, G. D., Fagan, A. M., Cobigo, Y., Brown, J. A., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.3812 · Cited by 130
Self-citationNeurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology
Nana, A. L., Sidhu, M., Gaus, S. E., Hwang, J.-H. L., Li, L., Park, Y., Kim, E.-J., Pasquini, L., Allen, I. E., Rankin, K. P., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1942-8 · Cited by 128
Self-citationTsapkini, K., Webster, K. T., Ficek, B. N., Desmond, J. E., Onyike, C. U., Rapp, B., Frangakis, C. E., & Hillis, A. E. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.08.002 · Cited by 122
Petersen, C., Nolan, A. L., de Paula França Resende, E., Miller, Z., Ehrenberg, A. J., Gorno-Tempini, M. L., Rosen, H. J., Kramer, J. H., Spina, S., Rabinovici, G. D., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02036-6 · Cited by 113
Self-citationAlcolea, D., Clarimón, J., Carmona‐Iragui, M., Illán‐Gala, I., Morenas‐Rodríguez, E., Barroeta, I., Ribosa‐Nogué, R., Sala, I., Sánchez‐Saudinós, M. B., Videla, L., et al. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.09.005 · Cited by 119
Henry, M. L., Hubbard, H. I., Grasso, S. M., Dial, H. R., Beeson, P. M., Miller, B. L., & Gorno-Tempini, M. L. (2019) · Journal of Speech, Language, and Hearing Research · doi:10.1044/2018_jslhr-l-18-0144 · Cited by 118
Self-citationCognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage
Ranasinghe, K. G., Rankin, K. P., Lobach, I. V., Kramer, J. H., Sturm, V. E., Bettcher, B. M., Possin, K., Christine You, S., Lamarre, A. K., Shany-Ur, T., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002373 · Cited by 112
Self-citationBenussi, A., Ashton, N. J., Karikari, T. K., Gazzina, S., Premi, E., Benussi, L., Ghidoni, R., Rodriguez, J. L., Emeršič, A., Binetti, G., et al. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-200608 · Cited by 113
“Disease severity was assessed with the FTLD modified Clinical Dementia Rating (FTLD-modified CDR) sum of boxes scale [38], while the level of functional independence was assessed with the Basic Activities of Daily Living (BADL) [39] and the Instrumental Activities of Daily Living (IADL)…”
Novak, P., Zilka, N., Zilkova, M., Kovacech, B., Skrabana, R., Ondrus, M., Fialova, L., Kontsekova, E., Otto, M., & Novak, M. (2019) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2018.45 · Cited by 112
Language and behavior domains enhance the value of the clinical dementia rating scale
Knopman, D. S., Weintraub, S., & Pankratz, V. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.006 · Cited by 105
Self-citationProposed research criteria for prodromal behavioural variant frontotemporal dementia
Barker, M. S., Gottesman, R. T., Manoochehri, M., Chapman, S., Appleby, B. S., Brushaber, D., Devick, K. L., Dickerson, B. C., Domoto-Reilly, K., Fields, J. A., et al. (2022) · Brain · doi:10.1093/brain/awab365 · Cited by 106
Self-citationRojas, J. C., Wang, P., Staffaroni, A. M., Heller, C., Cobigo, Y., Wolf, A., Goh, S.-Y. M., Ljubenkov, P. A., Heuer, H. W., Fong, J. C., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011848 · Cited by 106
Self-citationTomé, S. O., Vandenberghe, R. R., Ospitalieri, S., Schoor, E. V., Tousseyn, T., Otto, M., Arnim, C. A. F. V., & Thal, D. R. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00934-5 · Cited by 112
Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials
Staffaroni, A. M., Ljubenkov, P. A., Kornak, J., Cobigo, Y., Datta, S., Marx, G., Walters, S. M., Chiang, K., Olney, N., Elahi, F. M., et al. (2019) · Brain · doi:10.1093/brain/awy319 · Cited by 105
Self-citationBallard, K. J., Savage, S., Leyton, C. E., Vogel, A. P., Hornberger, M., & Hodges, J. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089864 · Cited by 105
“Average disease severity scores, as measured by the Frontotemporal Lobar Degenerationmodified Clinical Dementia Rating Scale (FTLD-CDR) [45] and Mini-Mental State Examination (MMSE) [46], for both groups fell in the mild range.”
BackgroundMethodOxytocin for frontotemporal dementia: A randomized dose-finding study of safety and tolerability
Finger, E. C., MacKinley, J., Blair, M., Oliver, L. D., Jesso, S., Tartaglia, M. C., Borrie, M., Wells, J., Dziobek, I., Pasternak, S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001133 · Cited by 100
GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition
Murley, A. G., Rouse, M. A., Jones, P. S., Ye, R., Hezemans, F. H., O’Callaghan, C., Frangou, P., Kourtzi, Z., Rua, C., Carpenter, T. A., et al. (2020) · Brain · doi:10.1093/brain/awaa305 · Cited by 100
Irwin, D. J., Trojanowski, J. Q., & Grossman, M. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00006 · Cited by 96
“…et al., 2008, 2011), which is most often associated with AD neuropathology (Mesulam et al., 2008; Rabinovici et al., 2008; Grossman, 2010) (Figure 1C), and therefore suggested to be excluded from FTLD clinical trials (Knopman et al., 2008), could influence group-wise CSF tau and Aβ1−42 results.”
BackgroundInfluentialDiagnosis and Management of Behavioral Issues in Frontotemporal Dementia
Manoochehri, M., & Huey, E. D. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0302-7 · Cited by 109
Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium
Miyagawa, T., Brushaber, D., Syrjanen, J., Kremers, W., Fields, J., Forsberg, L. K., Heuer, H. W., Knopman, D., Kornak, J., Boxer, A., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.05.013 · Cited by 92
Self-citationDucharme, S., Price, B. H., Larvie, M., Dougherty, D. D., & Dickerson, B. C. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14101248 · Cited by 98
Jiskoot, L. C., Panman, J. L., Meeter, L. H., Dopper, E. G. P., Donker Kaat, L., Franzen, S., van der Ende, E. L., van Minkelen, R., Rombouts, S. A. R. B., Papma, J. M., et al. (2019) · Brain · doi:10.1093/brain/awy288 · Cited by 91
Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries
Logroscino, G., Piccininni, M., Graff, C., Hardiman, O., Ludolph, A. C., Moreno, F., Otto, M., Remes, A. M., Rowe, J. B., Seelaar, H., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2022.5128 · Cited by 91
Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias
Steinacker, P., Semler, E., Anderl-Straub, S., Diehl-Schmid, J., Schroeter, M. L., Uttner, I., Foerstl, H., Landwehrmeyer, B., von Arnim, C. A. F., Kassubek, J., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003688 · Cited by 89
Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year
Knopman, D. S., Jack, C. R., Kramer, J. H., Boeve, B. F., Caselli, R. J., Graff-Radford, N. R., Mendez, M. F., Miller, B. L., & Mercaldo, N. D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a71236 · Cited by 85
Self-citationThe effect of tDCS on functional connectivity in primary progressive aphasia
Ficek, B., Wang, Z., Zhao, Y., Webster, K. T., Desmond, J. E., Hillis, A. E., Frangakis, C., Faria, A. V., Caffo, B. S., & Tsapkini, K. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.05.023 · Cited by 97
CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum
Illán-Gala, I., Alcolea, D., Montal, V., Dols-Icardo, O., Muñoz, L., de Luna, N., Turón-Sans, J., Cortés-Vicente, E., Sánchez-Saudinós, M. B., Subirana, A., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006383 · Cited by 85
Prado, P., Medel, V., Gonzalez-Gomez, R., Sainz-Ballesteros, A., Vidal, V., Santamaría-García, H., Moguilner, S., Mejia, J., Slachevsky, A., Behrens, M. I., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02806-8 · Cited by 79
Structural brain imaging in frontotemporal dementia
Rohrer, J. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.014 · Cited by 101
Bickart, K. C., Brickhouse, M., Negreira, A., Sapolsky, D., Barrett, L. F., & Dickerson, B. C. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304656 · Cited by 75
Giving Words New Life: Generalization of Word Retraining Outcomes in Semantic Dementia
Savage, S. A., Piguet, O., & Hodges, J. R. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131826 · Cited by 74
Measuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study
Gordon, E., Rohrer, J. D., Kim, L. G., Omar, R., Rossor, M. N., Fox, N. C., & Warren, J. D. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d1a879 · Cited by 70
Boxer, A. L., Gold, M., Feldman, H., Boeve, B. F., Dickinson, S. L.-J., Fillit, H., Ho, C., Paul, R., Pearlman, R., Sutherland, M., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.4956 · Cited by 71
Self-citationLongitudinal Grey and White Matter Changes in Frontotemporal Dementia and Alzheimer’s Disease
Frings, L., Yew, B., Flanagan, E., Lam, B. Y. K., Hüll, M., Huppertz, H.-J., Hodges, J. R., & Hornberger, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090814 · Cited by 69
Prefrontal cortex rTMS enhances action naming in progressive non‐fluent aphasia
Cotelli, M., Manenti, R., Alberici, A., Brambilla, M., Cosseddu, M., Zanetti, O., Miozzo, A., Padovani, A., Miniussi, C., & Borroni, B. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03699.x · Cited by 69
Borroni, B., Agosti, C., Premi, E., Cerini, C., Cosseddu, M., Paghera, B., Bellelli, G., & Padovani, A. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02911.x · Cited by 65
“In a longitudinal multicentre study, the Consortium of Mayo Clinic and University of California FTLD Centers have recently suggested that FTLD-modified CDR may be used as outcome measure in future clinical trials [7].”
BackgroundMethodInfluentialPakhomov, S. V. S., Smith, G. E., Chacon, D., Feliciano, Y., Graff-Radford, N., Caselli, R., & Knopman, D. S. (2010) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181c5dde3 · Cited by 64
Self-citationElahi, F. M., Marx, G., Cobigo, Y., Staffaroni, A. M., Kornak, J., Tosun, D., Boxer, A. L., Kramer, J. H., Miller, B. L., & Rosen, H. J. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2017.09.007 · Cited by 59
Self-citationNon-pharmacological Management of Behavioral Symptoms in Frontotemporal and Other Dementias
Barton, C., Ketelle, R., Merrilees, J. J., & Miller, B. L. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0618-1 · Cited by 77
Self-citationBrain volumes as predictors of tDCS effects in primary progressive aphasia
de Aguiar, V., Zhao, Y., Faria, A. V., Ficek, B., Webster, K. T., Wendt, H., Wang, Z., Hillis, A. E., Onyike, C. U., Frangakis, C., et al. (2019) · Brain and Language · doi:10.1016/j.bandl.2019.104707 · Cited by 74
Oliver, L. D., Mitchell, D. G. V., Dziobek, I., MacKinley, J. D., Coleman, K. K. L., Rankin, K. P., & Finger, E. C. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.11.022 · Cited by 76
Pakhomov, S. V. S., & Hemmy, L. S. (2014) · Cortex · doi:10.1016/j.cortex.2013.05.009 · Cited by 61
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
Goldman, J. G., Forsberg, L. K., Boeve, B. F., Armstrong, M. J., Irwin, D. J., Ferman, T. J., Galasko, D. R., Galvin, J. E., Kaufer, D., Leverenz, J. B., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00703-5 · Cited by 67
Self-citationIllán-Gala, I., Montal, V., Borrego-Écija, S., Vilaplana, E., Pegueroles, J., Alcolea, D., Sánchez-Saudinós, B., Clarimón, J., Turón-Sans, J., Bargalló, N., et al. (2019) · Brain · doi:10.1093/brain/awz031 · Cited by 60
Self-citationConceptual framework for the definition of preclinical and prodromal frontotemporal dementia
Benussi, A., Alberici, A., Samra, K., Russell, L. L., Greaves, C. V., Bocchetta, M., Ducharme, S., Finger, E. C., Fumagalli, G., Galimberti, D., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12485 · Cited by 67
Borroni, B., Premi, E., Agosti, C., Alberici, A., Garibotto, V., Bellelli, G., Paghera, B., Lucchini, S., Giubbini, R., Perani, D., et al. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000235575 · Cited by 65
Reul, S., Lohmann, H., Wiendl, H., Duning, T., & Johnen, A. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0287-1 · Cited by 59
Ramani, S., Berard, J. A., & Walker, L. A. S. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117229 · Cited by 61
Santillo, A. F., Mårtensson, J., Lindberg, O., Nilsson, M., Manzouri, A., Landqvist Waldö, M., van Westen, D., Wahlund, L.-O., Lätt, J., & Nilsson, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066932 · Cited by 57
Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17
Ghetti, B., Wszolek, Z. K., Boeve, B. F., Spina, S., & Goedert, M. (2011) · Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders · doi:10.1002/9781444341256.ch14 · Cited by 57
Self-citationPredicting functional decline in behavioural variant frontotemporal dementia
Josephs, K. A., Whitwell, J. L., Weigand, S. D., Senjem, M. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Jack, C. R., & Petersen, R. C. (2011) · Brain · doi:10.1093/brain/awq348 · Cited by 56
Self-citationPatterns of Brain Atrophy in Clinical Variants of Frontotemporal Lobar Degeneration
Lu, P. H., Mendez, M. F., Lee, G. J., Leow, A. D., Lee, H.-W., Shapira, J., Jimenez, E., Boeve, B. B., Caselli, R. J., Graff-Radford, N. R., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000345523 · Cited by 55
Self-citationOff-Label Medication Use in Frontotemporal Dementia
Hu, B., Ross, L., Neuhaus, J., Knopman, D., Kramer, J., Boeve, B., Caselli, R. J., Graff-Radford, N., Mendez, M. F., Miller, B. L., et al. (2010) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317509356692 · Cited by 56
Self-citationCognitive and behavioural inhibition deficits in neurodegenerative dementias
Migliaccio, R., Tanguy, D., Bouzigues, A., Sezer, I., Dubois, B., Ber, I. L., Batrancourt, B. M., Godefroy, V., & Lévy, R. (2020) · Cortex · doi:10.1016/j.cortex.2020.08.001 · Cited by 71
Rosen, H. J., Boeve, B. F., & Boxer, A. L. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12004 · Cited by 55
Self-citationConca, F., Esposito, V., Giusto, G., Cappa, S. F., & Catricalà, E. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101760 · Cited by 54
Clinico-genetic findings in 509 frontotemporal dementia patients
Wagner, M., Lorenz, G., Volk, A. E., Brunet, T., Edbauer, D., Berutti, R., Zhao, C., Anderl‐Straub, S., Bertram, L., Danek, A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01271-2 · Cited by 61
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia
Kerchner, G. A., Tartaglia, M. C., & Boxer, A. L. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.6 · Cited by 59
Boxer, A. L., Gold, M., Huey, E., Hu, W. T., Rosen, H., Kramer, J., Gao, F., Burton, E. A., Chow, T., Kao, A., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.03.003 · Cited by 54
Self-citationSchönecker, S., Neuhofer, C. M., Otto, M., Ludolph, A. C., Kassubek, J., Landwehrmeyer, G. B., Anderl‐Straub, S., Semler, E., Diehl‐Schmid, J., Prix, C., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00045 · Cited by 61
Symptom‐led staging for semantic and non‐fluent/agrammatic variants of primary progressive aphasia
Hardy, C. J. D., Taylor‐Rubin, C., Taylor, B., Harding, E., Gonzalez, A. S., Jiang, J., Thompson, L. M., Kingma, R. M., Chokesuwattanaskul, A., Walker, F., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13415 · Cited by 63
Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers
Lee, S. E., Sias, A. C., Kosik, E. L., Flagan, T. M., Deng, J., Chu, S. A., Brown, J. A., Vidovszky, A. A., Ramos, E. M., Gorno-Tempini, M. L., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101751 · Cited by 53
Self-citationReductions in GABA following a tDCS-language intervention for primary progressive aphasia
Harris, A. D., Wang, Z., Ficek, B., Webster, K., Edden, R. A. E., & Tsapkini, K. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.011 · Cited by 55
Automatic Subtyping of Individuals with Primary Progressive Aphasia
Themistocleous, C., Ficek, B., Webster, K., den Ouden, D.-B., Hillis, A. E., & Tsapkini, K. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201101 · Cited by 51
“We used the revised Frontotemporal Dementia Clinical Dementia Rating (FTD-CDR) scale to rate severity of PPA [16].”
MethodRates of Hemispheric and Lobar Atrophy in the Language Variants of Frontotemporal Lobar Degeneration
Rohrer, J. D., Clarkson, M. J., Kittus, R., Rossor, M. N., Ourselin, S., Warren, J. D., & Fox, N. C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111556 · Cited by 51
Establishing two principal dimensions of cognitive variation in logopenic progressive aphasia
Ramanan, S., Roquet, D., Goldberg, Z.-L., Hodges, J. R., Piguet, O., Irish, M., & Ralph, M. A. L. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa125 · Cited by 49
Cividini, C., Basaia, S., Spinelli, E. G., Canu, E., Castelnovo, V., Riva, N., Cecchetti, G., Caso, F., Magnani, G., Falini, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000013123 · Cited by 56
Pasquini, L., Nana, A. L., Toller, G., Brown, J. A., Deng, J., Staffaroni, A., Kim, E.-J., Hwang, J.-H. L., Li, L., Park, Y., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa119 · Cited by 50
Self-citationCerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
Ljubenkov, P. A., Staffaroni, A. M., Rojas, J. C., Allen, I. E., Wang, P., Heuer, H., Karydas, A., Kornak, J., Cobigo, Y., Seeley, W. W., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.643 · Cited by 49
Self-citationTMS for staging and predicting functional decline in frontotemporal dementia
Benussi, A., Dell’Era, V., Cantoni, V., Cotelli, M. S., Cosseddu, M., Spallazzi, M., Micheli, A., Turrone, R., Alberici, A., & Borroni, B. (2019) · Brain stimulation · doi:10.1016/j.brs.2019.11.009 · Cited by 50
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration
Casaletto, K. B., Staffaroni, A. M., Wolf, A., Appleby, B., Brushaber, D., Coppola, G., Dickerson, B., Domoto‐Reilly, K., Elahi, F. M., Fields, J., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12001 · Cited by 48
Self-citationWritten Verb Naming Improves After tDCS Over the Left IFG in Primary Progressive Aphasia
Fenner, A. S., Webster, K. T., Ficek, B., Frangakis, C., & Tsapkini, K. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01396 · Cited by 55
Zhao, Y., Ficek, B., Webster, K. T., Frangakis, C., Caffo, B. C., Hillis, A. E., Faria, A. V., & Tsapkini, K. (2020) · Neurorehabilitation and neural repair · doi:10.1177/1545968320971741 · Cited by 57
Staffaroni, A. M., Bajorek, L., Casaletto, K. B., Cobigo, Y., Goh, S. M., Wolf, A., Heuer, H. W., Elahi, F. M., Ljubenkov, P. A., Dever, R., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.012 · Cited by 47
Self-citationCosseddu, M., Benussi, A., Gazzina, S., Alberici, A., Dell'Era, V., Manes, M., Cristillo, V., Borroni, B., & Padovani, A. (2020) · European Journal of Neurology · doi:10.1111/ene.14071 · Cited by 47
Staffaroni, A. M., Goh, S.-Y. M., Cobigo, Y., Ong, E., Lee, S. E., Casaletto, K. B., Wolf, A., Forsberg, L. K., Ghoshal, N., Graff-Radford, N. R., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22847 · Cited by 41
Self-citationBarschke, P., Oeckl, P., Steinacker, P., Al Shweiki, M. R., Weishaupt, J. H., Landwehrmeyer, G. B., Anderl-Straub, S., Weydt, P., Diehl-Schmid, J., Danek, A., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322476 · Cited by 45
de Aguiar, V., Zhao, Y., Ficek, B., Webster, K. T., Rofes, A., Wendt, H., Frangakis, C., Caffo, B. S., Hillis, A. E., Rapp, B. C., et al. (2019) · Cortex · doi:10.1016/j.cortex.2019.11.001 · Cited by 51
Modirrousta, M., Price, B. H., & Dickerson, B. C. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.6 · Cited by 54
Tao, Y., Ficek, B., Rapp, B. C., & Tsapkini, K. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.007 · Cited by 47
Kim, E., Kwon, J. C., Park, K. H., Park, K.-W., Lee, J., Choi, S. H., Jeong, J. H., Kim, B. C., Yoon, S. J., Yoon, Y. C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.033 · Cited by 49
Nardell, M., & Tampi, R. R. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513507375 · Cited by 51
Cognitive Intervention in Semantic Dementia: Maintaining Words Over Time
Savage, S. A., Piguet, O., & Hodges, J. R. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000053 · Cited by 44
DAPHNE: a new tool for the assessment of the behavioral variant of frontotemporal dementia
Boutoleau-Bretonnière, C., Evrard, C., Hardouin, J. B., Rocher, L., Charriau, T., Etcharry-Bouyx, F., Auriacombe, S., Richard-Mornas, A., Lebert, F., Pasquier, F., et al. (2015) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000440859 · Cited by 44
FOXP2, APOE, and PRNP: New Modulators in Primary Progressive Aphasia
Premi, E., Pilotto, A., Alberici, A., Papetti, A., Archetti, S., Seripa, D., Daniele, A., Masullo, C., Garibotto, V., Paghera, B., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111541 · Cited by 45
Sollberger, M., Neuhaus, J., Ketelle, R., Stanley, C. M., Beckman, V., Growdon, M., Jang, J., Miller, B. L., & Rankin, K. P. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.205047 · Cited by 43
Self-citation
Metadata
- Authors
- Knopman, D. S., Kramer, J. H., Boeve, B. F., Caselli, R. J., Graff-Radford, N. R., Mendez, M. F., Miller, B. L., & Mercaldo, N.
- Affiliations
- Mayo Clinic (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-21
- Volume
- 131
- Issue
- 11
- Pages
- 2957-2968
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC2725027
- OpenAlex
- W1984148891
- Cited by
- 442
- References
- 48
- Citations by year
- 2026: 25 · 2025: 31 · 2024: 36 · 2023: 28 · 2022: 30 · 2021: 41 · 2020: 49 · 2019: 36 · 2018: 26 · 2017: 13 · 2016: 20 · 2015: 17 · 2014: 21 · 2013: 20 · 2012: 14
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30-AG-19610, P50‐AG16574, U01AG016976, P50AG016570, P30AG019610, R01AG023195, P01AG019724, P50AG023501, P50AG016574)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- frontotemporal lobar degeneration, clinical trial design, outcome measures, disease progression, behavioral variant frontotemporal dementia, progressive nonfluent aphasia, semantic dementia, neuropsychological assessment, Clinical Global Impression of Change, Neuropsychiatric Inventory, floor and ceiling effects, language loss, executive function decline
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aphasia, Cognition Disorders, Dementia, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Research Design, Randomized Controlled Trials as Topic, Outcome Assessment, Health Care, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.